Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

CPH/SMSMED stock hub

CPH/SMSMED has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CPH/SMSMEDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

82.6M

Copenhagen Stock Exchange

Market data

Price

Recent price action with selectable time range.

CPH/SMSMEDCPH/SMSMED

—

Loading chart…

In the news

Latest news · CPH/SMSMED

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E3,176.3

P25 n/aP50 n/aP75 n/a

ROE0

P25 n/aP50 n/aP75 n/a

ROIC0.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CPH/SMSMED market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

198

Groups with data

Currency

DKK

Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Denmark
Country code	DK
Employees	29
Employees Change	3%
Employees Change Percent	11.54
Enterprise value	DKK 144M
Exchange	Copenhagen Stock Exchange
Financial currency	DKK
First seen	2026-05-10
Industry	Medical Devices
Isin	DK0061675006
Last refreshed	2026-05-10
Market cap	DKK 82.6M
Price	DKK 2.97
Price currency	DKK
Rev Per Employee	8,463,517.24x
Sector	Healthcare
Sic	5047
Symbol	cph/SMSMED
Website	https://www.scandinavian-medical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.03%
EV Earnings	5,536.95x
EV/EBIT	80.47x
EV/EBITDA	13.83x
EV/FCF	-4.21x
EV/Sales	0.59x
FCF yield	-41.44%
P/B ratio	1x
P/E ratio	3,176.3x
P/S ratio	0.34x
PE Ratio10 Y	291.53x
PE Ratio3 Y	743.93x
PE Ratio5 Y	456.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.73%
EBITDA Margin	4.24%
Gross margin	13.97%
Gross Profit	DKK 34.3M
Gross Profit Growth	-2.75%
Gross Profit Growth Q	-4.18%
Gross Profit Growth3 Y	3.25%
Gross Profit Growth5 Y	-0.12%
Net Income	DKK 26,000
Net Income Growth	-99.67%
Net Income Growth Q	-54.06%
Net Income Growth Years	0%
Net Income Growth3 Y	-83.08%
Net Income Growth5 Y	-72.42%
Pretax Margin	0.09%
Profit Margin	0.01%
Profit Per Employee	DKK 897
Profitable Years	7
ROA	0.59
Roa5y	9.52
ROCE	1.56
ROE	0.03
Roe5y	22.1
ROIC	0.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-31.74%
Cagr3y	-34.86%
EPS Growth	-99.67
EPS Growth Q	-54.37
EPS Growth Years	0
EPS Growth3 Y	-83.15
EPS Growth5 Y	-72.51
Revenue Growth	8.28x
Revenue Growth Q	-1.15x
Revenue Growth Years	6x
Revenue Growth3 Y	7.51x
Revenue Growth5 Y	9.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	DKK 1.29
Assets	DKK 205.9M
Cash	DKK 2.1M
Current Assets	DKK 141.8M
Current Liabilities	DKK 91M
Debt	DKK 63.5M
Debt EBITDA	DKK 6.1
Debt Equity	DKK 0.77
Debt FCF	DKK -1.86
Equity	DKK 82.7M
Interest Coverage	0.83
Liabilities	DKK 123.2M
Long Term Assets	DKK 64M
Long Term Liabilities	DKK 32.2M
Net Cash	DKK -61.4M
Net Cash By Market Cap	DKK -74.32
Net Debt EBITDA	DKK 5.89
Net Debt Equity	DKK 0.74
Tangible Book Value	DKK 82.7M
Tangible Book Value Per Share	DKK 2.99
WACC	3.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.56
Inventory Turnover	2.17
Net Working Capital	DKK 81.8M
Quick ratio	0.33
Working Capital	DKK 50.8M
Working Capital Turnover	DKK 5.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-31.72%
200-day SMA	3.9
3Y total return	-72.37%
50-day SMA	3.19
50-day SMA vs 200-day SMA	50under200
All Time High	14.18
All Time High Change	-79.06%
All Time High Date	2023-02-27
All Time Low	2.76
All Time Low Change	7.61%
All Time Low Date	2026-04-13
ATR	0.18
Beta	0.25
Beta1y	-0.14
Beta2y	0.12
Ch YTD	-32.65
High	2.98
High52	5.46
High52 Date	2025-05-12
High52ch	-45.6%
Low	2.88
Low52	2.76
Low52 Date	2026-04-13
Low52ch	7.61%
Ma50ch	-6.9%
Price vs 200-day SMA	-23.85%
RSI	44.85
RSI Monthly	31.08
RSI Weekly	34.9
Sharpe ratio	-0.44x
Sortino ratio	-0.57
Total Return	-0.67%
Tr YTD	-32.65
Tr1m	-5.11%
Tr1w	-0.67%
Tr3m	-16.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	DKK 1.8M
Operating Income Growth	-68.7
Operating Income Growth Q	-42.88
Operating Income Growth3 Y	-40.61
Operating Income Growth5 Y	-39.23
Operating margin	0.73

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	24,476,000
Shares Out	27,806,000
Shares Qo Q	0.33%
Shares Yo Y	0.67%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	DKK -34.2M
Average Volume	29,169.9x
Bv Per Share	2.99
CAPEX	DKK -20.8M
Ch1m	-5.11
Ch1w	-0.67
Ch1y	-31.72
Ch3m	-16.81
Ch3y	-72.37
Ch6m	-28.61
Change	2.41%
Change From Open	2.41
Close	2.9
Days Gap	0
Depreciation Amortization	8,623,000
Dollar Volume	12,447.3
Earnings Date	2026-05-13
EBIT	DKK 1.8M
EBITDA	DKK 10.4M
EPS	DKK 0
F Score	2
FCF	DKK -34.2M
FCF EV Yield	-23.77x
FCF Per Share	DKK -1.23
Financing CF	24,721,000
Fiscal Year End	September
Founded	2,018
Graham Number	0.25129
Graham Upside	-91.54
Income Tax	DKK 189,000
Investing CF	-19,844,000
Is Primary Listing	1
Last Earnings Date	2026-02-13
Last Report Date	2025-09-30
Lynch Fair Value	DKK 0
Lynch Upside	-99.84
Ma150	3.77
Ma150ch	-21.16%
Ma20	3.06
Ma20ch	-2.81%
Net CF	-8,657,000
Next Earnings Date	2026-05-13
Open	2.9
Position In Range	90
Ppne	62,637,000
Price Date	2026-05-08
Price EBITDA	DKK 7.93
Ptbv Ratio	1
Relative Volume	0.14x
Revenue	245,442,000x
Tax By Revenue	0.08x
Tax Rate	87.91%
Tr6m	-28.61%
Volume	4,191
Z Score	2.76

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CPH/SMSMED pay a dividend?

Capital-return profile for this ticker.

Performance

CPH/SMSMED stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CPH/SMSMED?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.7%

Negative means the company is buying back shares.

Technical

CPH/SMSMED momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.8

Neutral momentum band

Price vs 200-day MA

-23.8%

50/200-day relationship not available

Beta (5Y)

0.25

Less volatile than the market

Sharpe ratio

-0.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CPH/SMSMED

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cph/SMSMED stock rating?

cph/SMSMED is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cph/SMSMED analysis?

The full report lives at /stocks/cph/SMSMED/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cph/SMSMED?

The latest report frames cph/SMSMED around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cph/SMSMED page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.